Home|Journals|Articles by Year|Audio Abstracts
 

Short Communication

J App Pharm Sci. 2022; 12(9): 180-190


Ethnopharmacological study of medicinal plants indigenous knowledge about low back pain therapy in Sumatra, Indonesia

Ulfatun Nisa, Agus Triyono, Danang Ardiyanto, Fajar Novianto, Ulfa Fitriani, Wayan D. Miftakhul Jannah, Peristiwan R. Widhi Astana, Zuraida Zulkarnain.




Abstract
Cited by 5 Articles

Indonesians have had a close relationship with traditional herbal medicine for ages to maintain their health. As a common disease in the community, low back pain (LBP) is always considered for traditional healers in their practice. However, there are still insufficient data regarding the use of medicinal plants for LBP treatment. An ethnopharmacological study was conducted in Sumatra, Indonesia, to gain information on the empirical use of medicinal plants for LBP therapy among traditional healers. The information on the use of medicinal plants was gathered using semistructured questionnaires and interviews with traditional healers. The collected data were analyzed using several parameters such as family use value (FUV), use value (UV), and plant part used. A total of 90 traditional healers in Sumatra cited 68 plant species in 32 families that are used in their herbal formula for LBP treatment. They prefer to use leaves, roots, and barks than other parts of a plant. The calculation result of UV reveals that Kaempferia galanga is the most common plant used for LBP (0.04). Zingiberaceae was categorized as having the highest FUV. Datura metel was a toxic plant. The phytochemical and pharmacological screening of the indicated therapeutic plants should be investigated.

Key words: Keywords: Low back pain, medicinal plants, ethnopharmacology, Indonesia






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.